Loading…
← CockpitCompetitor Analysis › CUPID.NS Cupid LimitedOpen in the cockpit ↗

Cupid LimitedCUPID.NSCompetitor analysis, valuation and peers

India · INR·FMCG›Household/Personal Care

Indian manufacturer of male and female condoms, lubricants and pregnancy test kits, largely sold via government/global tenders.

≈ A niche Indian condom/contraceptive manufacturerMomentum leader 99
Mkt cap
$5.22B
US dollars, full cap
Free float
33%
of shares outstanding
$/day
$50.1M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
+8.1 pp
WACC 12.5%
Hurdle
n/a
no reverse DCF
Close · INR₹363.20
1D-0.7%
1W+2.6%
1M+8.0%
3M+27.9%
6M+217.7%
YTD+250.5%
1Y+549.9%
ATR %4.5%
Beta0.70
52w lowhigh7.6% off high

What Cupid does

Indian manufacturer of male and female condoms, lubricants and pregnancy test kits, largely sold via government/global tenders.

Most sales are won in competitive tenders from health ministries and international agencies buying condoms for public health programmes, so volumes are lumpy and depend on winning orders and keeping international quality approvals. Retail and export sales under its own labels are a smaller outlet.

In one line: A niche Indian condom/contraceptive manufacturer.

Products and services

  • Male condoms
  • Female condoms
  • Lubricants
  • Pregnancy/diagnostic test kits

Customers

  • Government health tenders (India & abroad)
  • International NGOs/health programs
  • Retail/export brands

Where it sits in the supply chain

  • Healthcare/consumer products
  • Contraceptive manufacturing
  • Condoms & sexual wellness products

What could go right

  • Government/global tender wins
  • Export demand growth

What could go wrong

  • Tender pricing pressure
  • Order lumpiness from institutional buyers

Moat: narrow (regulatory licence, process know-how). WHO/international pre-qualification and manufacturing scale for female condoms, a niche few make.

Headquarters: Gujarat, India · Founded: 1993 · Employees: 235

Named competitors

Cupid at a glance

Size Cupid (CUPID.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $5.22B, the 208th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹363.20 on 18 Nov 2026.

Performance Over six months the shares gained 217.7%, against -2.5% for the median peer and +3.8% for the India market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue grew 125.0% over the last twelve months (peer median +6.8%); the operating margin is 32.6% (peer median 12.3%).

Valuation It trades at 88.0× enterprise value to sales against a peer median of 1.9× (most expensive of 21).

Capital Return on invested capital runs 8.1 points above its cost of capital (12.5% WACC).

Relative performance

10020030021 May 202621 Aug 202618 Nov 2026CUPID.NS 304Peer median 101
Six months, rebased to 100: Cupid against the median of its 20 peers (local-currency closes).

Cupid financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹5.56B₹3.53B₹1.81B₹1.68B₹1.55B
Revenue growth—+95%+8%+8%—
Gross profit₹2.63B₹1.59B₹725M₹820M₹649M
EBITDA₹1.87B₹1.15B₹411M₹483M₹385M
Net income₹1.69B₹1.08B₹409M₹399M₹316M
Free cash flown/a₹375M-₹158M-₹143M₹335M
Capital expendituren/a₹247M₹195M₹250M₹25.4M
Total debt₹1.14B₹564M₹190M₹121M₹59.7M

Quarterly statements and history in the cockpit →

Cupid competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+100%+200%0%+20%REYNCOLPAL1318090430IPAR278470ELF45274912DABURCOTY10444967603605051900GODREJCP4911192820CUPID.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Cupid is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%25×50×75×REYNCOLPAL1318090430278470ELF051900192820CUPID.NSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Cupid is the large dot.

Cupid competitors and peer comparison

Head to head with its named competitors (CUPID.NS vs RKT.L vs 5122.T vs CHD)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
Cupid CUPID.NS$5.22B+218%+125%33%88.0×n/a
Reckitt Benckiser RKT.L$47.5B+22%-2%28%3.3×2.1%
Okamoto Industries 5122.T$651M+13%+5%7%0.6×n/a
Church & Dwight CHD$26.4B+16%+2%18%4.5×7.7%
Mankind Pharma MANKIND.NS$11.6B+5%+13%21%7.2×28.6%

How Cupid compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Cupid against its 20 peers (data as of 18 Nov 2026)
MeasureCUPID.NSPeer medianRank in peer set
1-month return+8.0%0.0%9th highest of 21
6-month return+217.7%-2.5%highest of 21
Distance from 52-week high-7.6%-21.0%7th highest of 21
Revenue growth (TTM)+125.0%+6.8%highest of 21
Operating margin32.6%12.3%highest of 21
EV / Sales88.0×1.9×most expensive of 21
ROIC minus cost of capital+8.1 pp+3.2 pp5th highest of 20
Net debt / EBITDA0.5×-0.4×7th most indebted of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Cupid CUPID.NSIndia$5.22B+218%+125%33%88.0×n/an/a
Reynolds Consumer Products REYNUnited States$5.28B+15%+2%14%1.8×0.8%+2.7%
Colgate-Palmolive (India) COLPAL.NSIndia$4.91B-23%+9%28%6.9×31.1%+4.5%
Mao Geping Cosmetics 1318.HKHong Kong$4.67B-8%+32%31%5.1×4.1%+41.1%
Amorepacific 090430.KSSouth Korea$6.01B0%+10%9%1.6×3.6%-0.8%
Interparfums IPARUnited States$4.28B+48%+3%18%3.0×10.5%+22.5%
APR 278470.KSSouth Korea$6.66B-45%+119%24%3.3×-2.3%+47.3%
e.l.f. Beauty ELFUnited States$6.73B+124%+40%14%3.8×24.1%+38.8%
Rohto Pharmaceutical 4527.TJapan$3.87B+8%+7%12%1.7×-2.8%+13.7%
Lion 4912.TJapan$3.85B+44%+6%8%1.3×0.9%+3.5%
Dabur India DABUR.NSIndia$7.16B-16%+9%15%4.6×27.4%+6.6%
Coty COTYUnited States$3.71B+116%0%5%1.2×9.8%+4.6%
Hengan Int'l 1044.HKHong Kong$3.27B-12%+2%11%1.0×-8.2%-0.1%
Kobayashi Pharmaceutical 4967.TJapan$3.25B+20%+2%6%2.8×18.0%+1.9%
Proya Cosmetics 603605.SSChina$2.87B-13%+2%13%1.4×-5.3%+23.1%
LG H&h 051900.KSSouth Korea$2.81B-14%-3%3%0.4×-4.6%-4.1%
Godrej Consumer Products GODREJCP.NSIndia$9.75B-12%+12%18%5.6×32.9%+6.6%
Gillette India GILLETTE.NSIndia$2.53B-5%+8%28%7.2×14.9%+13.0%
Winner Medical 300888.SZChina$2.53B-6%+4%11%1.4×-5.2%-2.6%
Shiseido 4911.TJapan$10.8B+47%+6%6%1.9×12.7%+1.0%
Cosmax 192820.KSSouth Korea$2.51B+53%+25%8%1.5×n/an/a

Questions

Who are Cupid's main competitors?
Named competitors: Karex Berhad (private or unlisted), Reckitt (Durex) (RKT.L), Okamoto Industries (5122.T), Church & Dwight (CHD), Mankind Pharma (MANKIND.NS). The cockpit's measured peer set (industry) also includes Reynolds Consumer Products (REYN), Colgate-Palmolive (India) (COLPAL.NS), Mao Geping Cosmetics (1318.HK), Amorepacific (090430.KS), Interparfums (IPAR), APR (278470.KS).
Is Cupid expensive compared with its peers?
On ev / sales it trades at 88.0× against a peer median of 1.9×, most expensive of 21 in its peer set.
How has Cupid stock performed?
Over six months to 18 Nov 2026 the shares returned +217.7% against -2.5% for the median peer; over one year +549.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.